Table 2.
Subgroup | Number (%) | VI (%) | |
---|---|---|---|
M (25%~75%) | Range | ||
Luminal A | 41 (18.2) | 5.9 (2.6~11.6) | 0~47.1 |
Luminal B HER-2-negative | 91 (40.4) | 7.3 (4.4~10.5) | 0~29.5 |
Luminal B HER-2-positive | 26 (11.6) | 6.3 (3.9~11.3) | 0.6~22.2 |
HER-2-positive | 17 (7.6) | 8.2 (4.9~15.6) | 0.9~54.4 |
Triple-negative | 50 (22.2) | 9.2 (5.1~15.3) | 0.7~32.9 |
Total | 225 (100) | 7.3 (4.2~11.8) | 0~54.4 |
Single-factor analysis of variance and Bonferroni correction showed no significant differences among the five subgroups (F = 1.855; P = 0.119) and any two subgroups (P > 0.05).
VI (%)M (25%~75%), Vascular index (%) Median (25%~75%); ER, estrogen receptor; HER-2, human epidermal growth factor receptor-2.